www.fdanews.com/articles/63021-advanced-neuromodulation-systems-receives-australian-regulatory-and-reimbursement-approval-for-rechargeable-chronic-pain-system
ADVANCED NEUROMODULATION SYSTEMS RECEIVES AUSTRALIAN REGULATORY AND REIMBURSEMENT APPROVAL FOR RECHARGEABLE CHRONIC PAIN SYSTEM
October 3, 2006
Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., announced Australian Therapeutic Goods Administration (TGA) regulatory approval for its Eon Rechargeable Neurostimulation System. In Australia, the Eon system is fully reimbursable via the private health system.
St. Jude Medical (http://phx.corporate-ir.net/test/phoenix.zhtml?c=73836&p=IROL-SingleRelease_print&t=NewsRelease&id=911455&highlight=)